Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 21, 2005Molecular Pharmaceutics

Iron Oxide Nanoparticles for Sustained Delivery of Anticancer Agents

View Full Paper
Ask AI
Bookmark
Share

Authors

TJTapan K. JainMMMarco A. MoralesSSSanjeeb Kumar Sahoo

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jain et al. (2005) studied this question.

synapsesocial.com/papers/6a7256e035aa2c282ce3355ahttps://doi.org/10.1021/mp0500014
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Synthesis of Monodisperse Superparamagnetic Fe/Silica Nanospherical Composites2003 · 257 citations
  2. 2Synthesis and Characterization of Soluble Iron Oxide−Dendrimer Composites2001 · 191 citations
  3. 3Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis2003 · 126 citations
  4. 4Surface-Modified Superparamagnetic Nanoparticles for Drug Delivery: Preparation, Characterization, and Cytotoxicity Studies2004 · 633 citations
  5. 5Iron—dextran antibody conjugates: General method for simultaneous staining of two components in high-resolution immunoelectron microscopy1979 · 72 citations